JPH0370498B2 - - Google Patents
Info
- Publication number
- JPH0370498B2 JPH0370498B2 JP14261983A JP14261983A JPH0370498B2 JP H0370498 B2 JPH0370498 B2 JP H0370498B2 JP 14261983 A JP14261983 A JP 14261983A JP 14261983 A JP14261983 A JP 14261983A JP H0370498 B2 JPH0370498 B2 JP H0370498B2
- Authority
- JP
- Japan
- Prior art keywords
- drug
- sheet
- skin
- carrier foil
- intermediate layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003814 drug Substances 0.000 claims description 77
- 229940079593 drug Drugs 0.000 claims description 71
- 239000011888 foil Substances 0.000 claims description 65
- 239000000853 adhesive Substances 0.000 claims description 48
- 239000010410 layer Substances 0.000 claims description 44
- 239000011505 plaster Substances 0.000 claims description 36
- 230000001070 adhesive effect Effects 0.000 claims description 35
- 238000000034 method Methods 0.000 claims description 29
- 238000007789 sealing Methods 0.000 claims description 16
- 238000004080 punching Methods 0.000 claims description 14
- 238000004806 packaging method and process Methods 0.000 claims description 11
- 230000001681 protective effect Effects 0.000 claims description 9
- 239000006260 foam Substances 0.000 claims description 7
- 239000011229 interlayer Substances 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 238000000151 deposition Methods 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 238000005553 drilling Methods 0.000 description 3
- 238000005304 joining Methods 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229920000298 Cellophane Polymers 0.000 description 2
- 238000004026 adhesive bonding Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000012173 sealing wax Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Landscapes
- Containers And Plastic Fillers For Packaging (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Description
【発明の詳細な説明】
この発明は、皮膚透過により投与される硬膏の
包装体を連続的に製造するために、薬剤を間隔を
おいて計量分づつシートの一部分に継続して収容
して薬剤をカバーシート片で被い、できた硬膏包
装体を打抜く方法に関する。DETAILED DESCRIPTION OF THE INVENTION In order to continuously manufacture plaster packages to be administered through skin permeation, the present invention involves continuously storing a measured amount of a drug at intervals in a portion of a sheet. This invention relates to a method for covering a plaster package with a piece of cover sheet and punching out the resulting plaster package.
前記硬膏包装体の一実施態様では、硬膏包装体
は皮膚の上に載せる部分と剥がして捨てる部分と
から成り、皮膚の上に載せる部分は発泡ゴム状の
皮膚付着シート、カバーシート片、計量分薬剤と
から成り、剥がして捨てる部分は担体箔と中間層
シートから成る。担体箔には引き剥がし用摘み片
を設けることができる。 In one embodiment of the plaster package, the plaster package consists of a part to be placed on the skin and a part to be peeled off and discarded, and the part to be placed on the skin includes a foam rubber-like skin adhesive sheet, a cover sheet piece, and a measuring portion. The part that is peeled off and thrown away is made up of a carrier foil and an intermediate layer sheet. The carrier foil can be provided with a peeling tab.
他の実施態様では担体箔に小深皿部を形成せ
ず、担体箔に盛つた薬剤の形態に合わせてカバー
シート片を小深皿状に予備形成して薬剤に被せ、
担体箔に接合する。そしてこれに中間層シートと
皮膚付着シートが加わるという構成である。 In another embodiment, a small deep dish portion is not formed on the carrier foil, but a cover sheet piece is preformed in a small deep dish shape according to the shape of the drug placed on the carrier foil, and is placed over the drug.
Bonded to carrier foil. In addition, an intermediate layer sheet and a skin adhesive sheet are added to this structure.
前記のような方法の一つはフランス特許
2082820号広報から知られている。このフランス
特許の方法では担体箔として接着帯が用いられ
る。即ち包装体の大きさの穴をあけられた金属製
の無端帯に結合されて用いられる。担体箔上に無
端帯の穴の領域でセロフアン小板が取り付けら
れ、セロフアン小板に薬剤を配量載置し、この薬
剤を被つた後この無端帯から担体箔が打ち抜かれ
る。 One such method is a French patent
Known from Public Relations No. 2082820. In the method of this French patent, an adhesive strip is used as carrier foil. That is, it is used by being connected to an endless metal band with holes the size of the package. A cellophane plate is attached to the carrier foil in the region of the holes in the endless strip, a drug is dispensed onto the cellophane plate, and after being coated with the drug the carrier foil is punched out of the endless strip.
このフランス特許の方法では結局接着帯のみが
金属搬送帯に設けた穴から打ち抜かれる。これは
実際には極めて困難な作業である。それは別とし
てもこの方法では少なくとも金属帯の穴の縁に接
着側が金属帯の方に向けられた接着帯が貼りつけ
られる。 In the process of this French patent, only the adhesive strip is ultimately punched out through holes provided in the metal carrier strip. This is actually an extremely difficult task. Apart from that, in this method at least the edge of the hole in the metal strip is affixed with an adhesive strip with the adhesive side facing the metal strip.
皮膚透過作用のある硬膏には時にリユーマチ治
療用が久しい以前から知られており、その薬剤は
強いペースト状にして適当な繊維織物の上に塗布
してあつて、付着側が、通常は二部に分かれて引
き離し可能なカバーシートで被われている。 Skin-permeable plasters have been known for a long time, sometimes for the treatment of rheumatoid arthritis, and the drug is made into a strong paste and applied onto a suitable textile fabric, with the adhesive side usually split into two parts. It is covered with a cover sheet that can be separated and pulled apart.
比較的大きい面に型切りされたこの種の硬膏は
手紙封筒状の紙袋に入れて売られる。時にはこの
種の硬膏は、長く保存していても効くように光・
気密性の袋の中に入つていることもある。 This type of plaster is cut into relatively large shapes and sold in paper bags shaped like letter envelopes. Sometimes this type of plaster is treated with light and light so that it remains effective even when stored for a long time.
Sometimes it's in an airtight bag.
そのうち、直接骨や筋肉に作用してはいけない
他の薬剤も皮膚透過式(即ち皮膚滲透)により投
与できることが分かつた。つまり服用又は座用に
しないのである。そのような場合にはそれらの部
位を傷つける場合がある。 Eventually, it was discovered that other drugs that should not directly act on bones and muscles can also be administered through the skin (ie, skin permeation). In other words, do not take it or use it for sitting. In such cases, those parts may be injured.
しかしこの種の薬剤貼用は一方では正確な配量
を必要とするが、また他方、薬剤が長期間有効で
あるようにするには、薬剤を皮膚に向かつてのみ
作用することができて、皮膚に貼用した後密閉被
覆したままにし、張用前も密閉包装されているよ
うな、特別な包装形態を前提とする。そうこうし
ているうちにこの種の包装体が開発された。それ
は所望の治療上の効果をも保証している。そのよ
うな包装体は初めに記載した種類の構造を有し、
販売に適した形態であり、分割後直ちに貼用可能
である。 However, this type of drug patch requires, on the one hand, precise dosing, and, on the other hand, in order for the drug to be effective for a long time, it must be able to act only towards the skin. A special packaging form is assumed, in which the product remains hermetically sealed after being applied to the skin, and is also hermetically sealed before application. In the meantime, this type of packaging was developed. It also guarantees the desired therapeutic effect. Such a package has a structure of the type mentioned at the outset,
It is in a format suitable for sale and can be applied immediately after being divided.
この種の硬膏包装は通常全体で五個の構成要素
からできていて、それらの構成要素は相互に一定
の仕方で密封可能で、その上なお比較的扁平で、
厚くは塗布しない形なので、この種の包装体は容
易には製造できないし、所望するように継続して
連続生産することはできない。特に構成要素の一
つが片側が皮膚に付着しなければならず、また前
記接着可能性自体は硬化後には最早接着性でなく
なるゲルによつて復活できなくなる。このゲルに
は薬剤が含まれている。即ち全製造工程において
接着能力のあるシートの加工も計算に入れておく
必要がある。これは前記フランス特許の方法では
少なくとも既に述べた理由から簡単にはできな
い。 This type of plaster packaging usually consists of a total of five components, which can be sealed to each other in a certain manner and which are still relatively flat.
Because the coating is not thick, this type of packaging is not easy to manufacture and cannot be continuously produced as desired. In particular, one of the components must adhere to the skin on one side, and the adhesive potential itself cannot be restored by the gel, which is no longer adhesive after curing. This gel contains drugs. That is, it is necessary to take into consideration the processing of sheets with adhesive ability in the entire manufacturing process. This cannot easily be done with the method of the French patent, at least for the reasons already mentioned.
従つてこの発明の基本課題は、この種の硬膏包
装体の連続製造方法の提供にあり、硬膏包装体の
形成要素である各シートを一工程で連続的に多層
に接合し、その間薬剤を充填し、できた包装体を
打ち抜くことにある。 Therefore, the basic problem of the present invention is to provide a method for continuous production of this type of plaster packaging, in which the sheets forming the plaster packaging are successively joined in multiple layers in one step, and during that time the sheets are filled with drugs. The purpose is to punch out the resulting package.
前記の硬膏包装体の一実施態様の構成を図示す
ると、第1〜3図に示す通りであつて、第1図に
は硬膏包装体のうちの、皮膚の上に載せる部分を
示してあり、符号4は泡ゴム状の皮膚付着シー
ト、3′はカバーシート片、5は計量分薬剤であ
る。第2図には硬膏包装体のうちの、剥がして捨
てる部分を示してある。ここで符号2は穴をあ
けた中間層シート、1は担体箔、5′は小深皿部
であり、15は担体箔に設けた引き剥がし用摘み
片である。そして第3図にこれら第1図及び第2
図に示したものから成る硬膏包装体全体の断面を
示してある。 The structure of one embodiment of the plaster package is illustrated in FIGS. 1 to 3, and FIG. 1 shows the part of the plaster package that is placed on the skin. Reference numeral 4 is a foam rubber-like skin adhesive sheet, 3' is a cover sheet piece, and 5 is a measured amount of medicine. FIG. 2 shows the part of the plaster package that is to be peeled off and discarded. Here, numeral 2 is an intermediate layer sheet with holes, 1 is a carrier foil, 5' is a small deep dish portion, and 15 is a peeling piece provided on the carrier foil. And Figure 3 shows these Figures 1 and 2.
A cross-section of the entire plaster package consisting of what is shown in the figure is shown.
この発明の前記課題は、一緒に給層される帯状
の中間層シートと皮膚付着シートを、計量分薬剤
を有する担体箔と閉鎖ステーシヨンの堆積マガジ
ンから取り出したカバーシート片とに結合する前
に分離して、中間層シートに計量分薬剤と同じ大
きさの穴をあけ、穴のあいた中間層シートと計量
分薬剤を収容している担体箔とを一緒に案内して
計量分薬剤の周囲で相互に接合し、その上に更に
皮膚付着シートの付着側を接着する、薬剤を間隔
をおいて計量分づつ帯状の担体箔の一部分に継続
して収容してできた硬膏包装体を打ち抜くことに
より達成される。 The object of the invention is to separate the interlayer sheet and the skin-adhesive sheet in the form of a strip, which are layered together, before joining the carrier foil with the dosed drug and the cover sheet piece taken from the deposition magazine of the closed station. Then, a hole of the same size as the measured amount of drug is made in the intermediate layer sheet, and the perforated intermediate layer sheet and the carrier foil containing the measured amount of drug are guided together so that they intertwine around the measured amount of drug. This is accomplished by punching out a plaster package made by continuously storing measured amounts of the drug at intervals in a portion of a strip-shaped carrier foil, on which the adhesive side of the skin-adhesive sheet is adhered. be done.
前記課題は、この発明の他の構成によれば、中
間層シートに予め穴をあけて担体箔と一緒に案内
して相互に接合し、次に計量分薬剤を中間層シー
トによつて被われていない担体箔の領域に収容し
て予め打ち抜かれたカバーシート片でこの計量分
薬剤を被い、カバーシート片を計量分薬剤の周囲
で担体箱に封着した後、中間層シートと分離して
ある皮膚付着シートを被着してできた硬膏包装体
を打ち抜くことにより解決される。 According to another configuration of the present invention, the above-mentioned problem can be solved by making holes in the intermediate layer sheet in advance and guiding it together with the carrier foil so that they are bonded to each other, and then the measured amount of drug is covered by the intermediate layer sheet. This dose of drug is covered with a pre-punched cover sheet piece placed in the area of the carrier foil that is not covered, and the cover sheet piece is sealed around the dose of drug to the carrier box and then separated from the intermediate layer sheet. This problem can be solved by punching out a plaster package made of a skin-adhesive sheet.
前記課題はまた、担体箔に計量分薬剤を収容
し、この計量分薬剤をカバーシート片で被い、計
量分薬剤の周囲で担体箔にカバーシート片を封着
し、次にカバーシート片と同じ大きさの穴をあけ
た中間層シートを給送し、これを担体箔に封着
し、封着されたカバーシート片の上から中間層シ
ートである保護シートと分離された皮膚付着シー
トの付着側を接着して、できた硬膏包装体を打ち
抜くことにより解決される。 The problem also includes accommodating a metered dose of drug in a carrier foil, covering the metered dose with a cover sheet piece, sealing the cover sheet piece to the carrier foil around the metered dose, and then sealing the cover sheet piece with the cover sheet piece. An intermediate layer sheet with holes of the same size is fed, this is sealed on a carrier foil, and the protective sheet, which is the intermediate layer sheet, and the separated skin adhesion sheet are placed over the sealed cover sheet piece. This problem is solved by gluing the adhesive side and punching out the resulting plaster package.
前記課題は更にまた、担体箔を積層した中間層
シートの上に計量分薬剤を収容し、この計量分薬
剤をカバーシート片で被い、計量分薬剤の周囲で
担体箔と中間層シートとカバーシート片とを封着
し、次に皮膚付着シートの付着側を中間層シート
の上から被着してできた硬膏包装体を打ち抜くこ
とにより解決される。 The problem is further solved by accommodating a measured amount of drug on an intermediate layer sheet laminated with carrier foil, covering this measured amount of drug with a cover sheet piece, and surrounding the measured amount of drug with the carrier foil, intermediate layer sheet, and cover. This problem is solved by sealing the sheet pieces together, then applying the adhesive side of the skin-adhesive sheet over the intermediate layer sheet, and punching out the resulting plaster package.
以上の各方法に共通することとして、先ず膏薬
投与の際必要な単一の硬膏包装体となる各帯状体
を個々に製造してそれらの帯状体を次の工程で計
量分薬剤の収容の後相互に接合するのではなく、
充填作業を含めて硬膏包装体を形成しながら各体
状体を段階的に接合するという一工程で行うのが
有利である。 What is common to each of the above methods is that each strip that becomes a single plaster package required for administering a plaster is manufactured individually, and then these strips are used in the next step to contain the measured amount of medicine. Rather than joining each other,
It is advantageous to carry out this in one step, including the filling operation, by joining the bodies in stages while forming the plaster package.
特許請求の範囲各項に記載した各方法は包装機
械工学上公知の部材と装置の使用によつて容易に
実施に移すことができる。なんとなればそのため
に用いられる公知の要素、たとえば穴打抜き、封
着工具、配量充填ステーシヨン、カバーシート片
堆積装置、引渡し堆積装置、箔ベルト或いはその
類似物のための貯蔵ロール保持器が直ちに使用可
能であるからである。前記の各公知要素は適切に
適合させた機枠における各段階で作業周期に合わ
せて制御し、配置し、駆動することができる。 Each method described in each claim can be easily carried out by using members and devices known in packaging mechanics. The known elements used for this purpose, such as punching holes, sealing tools, dosing stations, cover sheet stacking devices, transfer stacking devices, storage roll holders for foil belts or the like, are immediately available. Because it is possible. The known elements mentioned above can be controlled, arranged and driven in accordance with the working cycle at each stage in a suitably adapted machine frame.
個々の包装構成要素には次の材料が特に問題に
なる。即ち
●ロールから引き離せる連続的アルミ担体箔で、
場合によつては薬剤の付着を防止する、塗布側
積層を有するもの、
●予め打抜かれたカバーシート片用の同じくアル
ミ箔で、少なくとも封印縁部領域に封ロウを備
えたもの、
●連続担体箔で封着可能な中間層シート用のシリ
コーン紙、
●皮膚付着性箔としての、薄くて、弾性のある泡
ゴム状箔で、片側に付着性接着剤を有するも
の、
である。 The following materials are of particular concern for individual packaging components: i.e. ● Continuous aluminum carrier foil that can be separated from the roll;
optionally with an application side laminate, which prevents the adhesion of the drug; ● also aluminum foil for pre-stamped cover sheet pieces, with sealing wax at least in the sealing edge area; ● a continuous carrier; Silicone paper for interlayer sheets that can be sealed with foil; ●Thin, elastic foam-rubber-like foil with adhesive adhesive on one side for use as skin-adhesive foil.
連続する担体箔を偏平な小深皿部に深絞りする
のは特に以上の方法の経過の枠内で行われる。何
となれば、そうすれば比較的大きくて濃い滴の形
で堆積されて薬剤を含むゲル状物質が僅かな圧力
で小深皿部の形にきめられて硬化するからであ
る。こうして、計量分薬剤が後に封印される硬膏
包装体の縁部領域に流れ込まないようになる。も
し流れ込むと完全な封印とはならない。 The deep drawing of a continuous carrier foil into a flat plate is carried out in particular within the framework of the process described above. This is because the drug-containing gel-like material, which is deposited in the form of relatively large, dense drops, is then compacted into a small dish shape and hardened under slight pressure. This prevents the dose from flowing into the edge area of the plaster package which is subsequently sealed. If it flows in, it will not be completely sealed.
それぞれの、担体箔の幅に従つて配量された薬
剤装入量が一列に相前後して或いは数列に相隣接
して相互に充分な間隔をおいて並ぶので、硬膏包
装体構成要素の封印と接着のために充分に大きな
縁部領域が使えるように残る。 The sealing of the plaster package components is ensured by the fact that the respective drug charges, which are dosed according to the width of the carrier foil, are arranged one after the other in a row or adjacently in several rows at a sufficient distance from each other. and leaves a large enough edge area available for gluing.
ゲル状の薬剤の堆積とか配量というのは、薬剤
がペースト状にも、またオブラート状にも硬化し
た状態で担体箔に付加されるという意味である。
しかし特にまだ硬化してないペースト状態で配量
添加される。何となれば、これは装置を用いてよ
り簡単に処理することができるし、その先の過程
で(たとえば硬化したゲル帯状体から打ち抜くこ
とができる)薬剤配合量のすべりを防止するため
に何も追加対策を講じる必要がないからである。 Deposition or dosing of a drug in the form of a gel means that the drug is applied to the carrier foil in the hardened state, both in the form of a paste and also in the form of a wafer.
However, it is especially metered in in the form of an uncured paste. After all, this can be handled more easily using equipment, and nothing can be done to prevent slippage of the drug formulation in the further process (which can be punched out of a hardened gel strip, for example). This is because there is no need to take additional measures.
特許請求の範囲9の変形例は別としてシリコ
ン・紙製の中間層シートに予め穴をあける。直径
は予め打ち抜かれたカバーシート片の直径よりや
や大きい。即ちそのような硬膏包装体中には一個
のリング形の中間層シートがある。完成してなお
もつながつている単一包装体は容易に分割可能で
あり、従つて薬剤の露出が容易である。そのよう
な分割を容易にするために各硬膏包装体の担体箔
の端縁部に切込みを設けた引き剥がし用つまみ片
を用意するのが好都合である。その場合封印領域
と接着領域の付着能力は、たとえば円形の硬膏包
装体に分割した後に包装体が二つの部分に分かれ
るように調整される。 Apart from the modification of claim 9, holes are made in advance in the intermediate layer sheet made of silicone and paper. The diameter is slightly larger than the diameter of the pre-punched cover sheet piece. That is, in such a plaster package there is a ring-shaped interlayer sheet. The completed, still connected unitary package can be easily split, thus facilitating exposure of the drug. To facilitate such division, it is advantageous to provide a tear-off tab with a notch in the edge of the carrier foil of each plaster package. The adhesion capacity of the sealing area and the adhesive area is then adjusted in such a way that, for example, after dividing into circular plaster packages, the package is divided into two parts.
皮膚に貼用できる部分は弾性の泡ゴム状皮膚付
着シートから成る。この皮膚付着シート上の中心
にはカバーシート片がある。このカバーシート片
は皮膚付着シートより直径が小さく、上に更に小
さい直径の、硬化した計量分薬剤が載つている。
この計量分薬剤は次に皮膚の上に貼用された後体
温の影響で緩やかに溶解し、皮膚に浸透する。そ
の際薬剤はカバーシート片に被われて反対側へ逃
げることができる。皮膚付着シートの付着縁の幅
が広いので、わきへははみ出さない。引き離され
た硬膏包装体の投棄部分は担体箔と封着されたま
まの中間層シートとから構成されている。 The part that can be applied to the skin consists of an elastic foam rubber-like skin adhesive sheet. At the center of this skin-adhesive sheet is a piece of cover sheet. This cover sheet strip is smaller in diameter than the skin adhesive sheet and has a smaller diameter cured dosage medicament thereon.
This measured amount of drug is then applied onto the skin, and then slowly dissolves under the influence of body temperature and penetrates into the skin. The drug is then covered by the cover sheet strip and can escape to the other side. Since the adhesive edge of the skin adhesive sheet is wide, it does not protrude into the armpit. The dumping part of the separated plaster package consists of the carrier foil and the intermediate sheet which remains sealed.
いくつかの実施例を示した図をもとに詳述す
る。第4図の例では、機枠の左側には担体箔1の
ロール1′と泡ゴム状の皮膚付着シート4のロー
ル4′がある。前記皮膚付着シートロールには同
時に、付着を防止するために中間層シート2或い
は保護シート2″を巻きつけてある。 A detailed description will be given based on figures showing some embodiments. In the example of FIG. 4, on the left side of the machine frame there are a roll 1' of carrier foil 1 and a roll 4' of foam rubber-like skin adhesive sheet 4. At the same time, an intermediate layer sheet 2 or a protective sheet 2'' is wrapped around the skin adhesion sheet roll to prevent adhesion.
補償ロール案内部14の通過後担体箔1は先ず
深絞りステーシヨン6において偏平な小深皿部
5′を備え、次にこれらの小深皿部中へ充填ステ
ーシヨン7において泥膏状の計量分薬剤を入れ
る。閉鎖ステーシヨン8では堆積マガジンから予
め打ち抜かれたカバーシート片3′が取り出され、
なお厚い滴状の計量分薬剤へ載せられ、軽く押さ
えつけられ、その際なお変形可能な薬剤の塊が当
該小深皿部5′中に一様に配分され、これをかな
り満たす(第3図)。次のステーシヨンは穴あけ
ステーシヨン9と封印ステーシヨン10との組合
せで、このステーシヨンの上部を穴あけのために
皮膚付着シート4から引き離された中間層シート
2のみが通り抜けて下方へ導かれ、穴の直径の大
きさを同じにして深絞りされかつ薬剤が充填され
た小深皿部5′を有する担体箔と共に案内されて、
このステーシヨンの下部で両者は封着される。即
ち二つのアルミ構成要素は封印され、穴のあいた
中間層シート2は担体箔1上に重ねて封着され
る。次のステーシヨンはここでは詳しく立ち入る
興味のないコード化ステーシヨン11で、この後
ろで皮膚付着シート4が分離桟13によるまだ穴
のあいていない中間層シート2の分離後の担体箔
上へ接着側が載せられる。次にこの全帯状体から
個別化ステーシヨン12で硬膏包装体が円形に打
ち抜かれ、図示していない配送・販売用厚紙包装
所に運ばれる。図から分かるように、この場合中
間層シート2は本来の走行方向に逆らつて逆戻り
して、先ず一片の適当な長さの中間層シートが先
行し、分離桟13の後方の接着シート部分が先ず
切断されなければならない。 After passing through the compensating roll guide 14, the carrier foil 1 is first provided with flat small basins 5' in a deep drawing station 6 and then into these small basins in a filling station 7 with a plaster-like metered dose of drug. Put in. In the closing station 8, the pre-punched cover sheet piece 3' is removed from the stacking magazine;
In addition, a thick droplet-like measured dose is placed on the drug and lightly pressed down, so that the still deformable mass of drug is evenly distributed in the small basin 5' and substantially fills it (FIG. 3). . The next station is a combination of a drilling station 9 and a sealing station 10, and only the intermediate layer sheet 2 separated from the skin adhering sheet 4 for drilling passes through the upper part of this station and is guided downward. guided together with a carrier foil having a small deep-drawn dish portion 5' of the same size and filled with a drug;
Both are sealed at the bottom of this station. The two aluminum components are thus sealed and the perforated interlayer sheet 2 is sealed one over the other onto the carrier foil 1. The next station is the coding station 11, which is of no interest here to go into detail, behind which the skin-adhesive sheet 4 is placed with its adhesive side onto the carrier foil after the separation of the still unperforated intermediate layer sheet 2 by means of the separating bar 13. It will be done. Next, plaster packages are punched out into circular shapes from this entire strip at a singulation station 12 and transported to a cardboard packaging facility for distribution and sales (not shown). As can be seen from the figure, in this case, the intermediate layer sheet 2 is reversed against the original running direction, so that a piece of the intermediate layer sheet of an appropriate length comes first, and the adhesive sheet portion behind the separation bar 13 It must be cut first.
第5図では対応するステーシヨンとシートに同
じ符号をつけてある。以上の方法の経過を説明す
ると次の通りである。 In FIG. 5, corresponding stations and seats are given the same reference numerals. The progress of the above method will be explained as follows.
穴のあいていない中間層シート2は特別のロー
ル2′の上にある。この特別のロールは前の段階
で皮膚付着シート4からの引き離しによつて生じ
たものである。穴あけステーシヨン9において中
間層シート2に穴があけられ、その後このシート
は穴のあいた中間層シート2として担体箔1と
共に封印ステーシヨン10に入る。この封印ステ
ーシヨンの後方で深絞りステーシヨン6において
穴のあいた中間層シート2の穴と同じ大きさの
直径の偏平な小深皿部5′が担体箔1に設けられ
る。ステーシヨン7において薬剤が充填され、次
にカバーシート片3′が載せられ、続いて担体箔
1に封着される。続いて皮膚付着シート4が載せ
られ、個別化ステーシヨン12において個々の包
装体の打抜きが行われる。 The unperforated interlayer sheet 2 lies on a special roll 2'. This particular roll resulted from the peeling off from the skin-adhesive sheet 4 in a previous step. Holes are punched in the intermediate layer sheet 2 at the punching station 9, after which this sheet enters the sealing station 10 together with the carrier foil 1 as the perforated intermediate layer sheet 2. Behind this sealing station, in a deep drawing station 6, a flat sub-dish 5' of the same size as the hole in the perforated intermediate layer sheet 2 is provided in the carrier foil 1. The drug is filled in the station 7 and then a cover sheet piece 3' is placed and subsequently sealed to the carrier foil 1. Subsequently, the skin-adhesive sheet 4 is placed and the individual packages are punched out at a singulation station 12.
第6図は別の変形例を示す。この場合先ず担体
箔1が深絞りステーシヨン6で深絞りされて小深
皿部が形成され、充填ステーシヨン7で薬剤が充
填され、閉鎖ステーシヨン8でカバーシートで被
われ、担体箔とカバーシート片は封印ステーシヨ
ン10で相互に封着される。中間層シート2は穴
あけステーシヨン9を通り、薬剤を充填されかつ
カバーをされた担体箔1まで運ばれる。封印ステ
ーシヨン10で穴あき中間層シート2の封着の
後皮膚付着シート4が、既載のようにその保護シ
ート2″から自由になつた後取付けられ、保護シ
ートは中間層シートロール2′として移動され、
中間層シート2として利用される。その後個別化
ステーシヨン12で単一包装体が打抜かれる。 FIG. 6 shows another modification. In this case, the carrier foil 1 is first deep-drawn in a deep-drawing station 6 to form a small deep dish, filled with the drug in a filling station 7 and covered with a cover sheet in a closing station 8, in which the carrier foil and the cover sheet piece are separated. They are mutually sealed at a sealing station 10. The intermediate layer sheet 2 is conveyed through a punching station 9 to a carrier foil 1 filled with drug and covered. After sealing the perforated intermediate layer sheet 2 at the sealing station 10, the skin-adhesive sheet 4 is attached after being freed from its protective sheet 2'' as described above, and the protective sheet is attached as an intermediate layer sheet roll 2'. moved,
It is used as the intermediate layer sheet 2. Single packages are then punched out at a singulation station 12.
第7図の方法は第6図のそれにかなり似てい
る。異なる点は、第7図の場合には計量分薬剤5
が硬化していて、ステーシヨン7の所で予め成形
されて担体箔1に載せられる。カバーシート片
3′が小深皿状に予備形成されて閉鎖ステーシヨ
ン8で計量分薬剤に被せられるか又は簡単な載置
の後付加形成されて封着される。その後は前例と
同様に穴があけられた中間層シート2の案内と
その封着と、皮膚付着シート4の取りつけ及び個
別化ステーシヨン12での単一包装体全体の打抜
きとが順に行われる。 The method of FIG. 7 is quite similar to that of FIG. The difference is that in the case of Fig. 7, the measured amount of drug 5
has been cured and is preformed and placed on the carrier foil 1 at the station 7. A cover sheet piece 3' is preformed in the form of a small saucer and placed over the metered dose in the closing station 8, or after a simple placement it is added and sealed. Thereafter, as in the previous example, the guiding and sealing of the perforated intermediate layer sheet 2, the attachment of the skin-adhesive sheet 4, and the punching of the entire single package at the singulation station 12 are carried out in this order.
第8図に示した変形例の場合には、中間層シー
ト2の穴はなくてもよい。何となれば担体箔1を
張つてあるこの中間層シートは担体箔と共に機械
の中に入るからである。つまり計量分薬剤5がス
テーシヨン7で中間層シートの上へ載せられるの
である。カバーシート片3′は場合によつては小
深皿形に予め形成され、計量分薬剤の上から中間
層シート被着され、封着される。その後に皮膚付
着シート4の取付けと単一包装体の打抜きが個別
化ステーシヨン12で行われる。 In the case of the modification shown in FIG. 8, the holes in the intermediate layer sheet 2 may not be provided. This is because this intermediate layer sheet covered with carrier foil 1 enters the machine together with the carrier foil. That is, the measured amount of medicine 5 is placed on the intermediate layer sheet at the station 7. The cover sheet piece 3' is optionally preformed in the shape of a small dish, and the intermediate layer sheet is placed over the dosed drug and sealed. The application of the skin-adhesive sheet 4 and the punching out of the single packages then take place in the singulation station 12.
第9〜11図には、第4図に示した方法の場合
に生じるシート個々の加工状態を示してある。 9 to 11 show the processing states of individual sheets that occur in the method shown in FIG. 4.
第1図は皮膚の上に載せる包装体の部分の平面
図、第2図は剥がして捨てる包装体の部分の平面
図、第3図は包装体全体の断面の極度の拡大図、
第4〜8図はそれぞれ異なる方法の実施に必要な
加工ステーシヨンの各種の配置を示す図式図、第
9〜11図は、第4図に示した方法の場合に生じ
る、シートの個々の加工状態を示す図である。こ
の発明の効果は、多層の包装体を、粘着シートの
加工も含めて一工程で連続製造できる点にある。
図中符号、1……担体箔、2……中間層シー
ト、2″……保護シート、3′……カバーシート
片、4……皮膚付着シート、5……計量分薬剤、
5′……小深皿部、7……充填ステーシヨン、8
……閉鎖ステーシヨン、9……穴あけステーシヨ
ン、10……封印ステーシヨン、12……個別化
ステーシヨン、14……補償ロール案内部。
Fig. 1 is a plan view of the part of the package to be placed on the skin, Fig. 2 is a plan view of the part of the package to be peeled off and discarded, and Fig. 3 is a highly enlarged cross-sectional view of the entire package;
4 to 8 are schematic diagrams showing the various arrangements of processing stations required for carrying out the different methods, and FIGS. 9 to 11 show the individual processing states of the sheet that occur in the case of the method shown in FIG. 4. FIG. The advantage of this invention is that multilayer packaging bodies can be continuously manufactured in one step, including processing of adhesive sheets. Symbols in the figure, 1... Carrier foil, 2... Intermediate layer sheet, 2''... Protective sheet, 3'... Cover sheet piece, 4... Skin adhesion sheet, 5... Measuring amount drug,
5'...Small deep dish section, 7...Filling station, 8
...Closing station, 9...Drilling station, 10...Sealing station, 12...Individuation station, 14...Compensation roll guide.
Claims (1)
分とから成り、皮膚に貼り付ける部分は、薬剤と
この薬剤を被うカバーシート片と更にその上の薄
く、弾力性がある発泡ゴム状の皮膚付着シートと
から成り、剥がして捨てる部分は薬剤を収容する
担体箔と、この担体箔と前記皮膚付着シートとの
接着を防止するためのリング状の中間層シートか
ら成る硬膏包装体を連続的に製造する方法におい
て、一緒に給送される帯状の中間層シート2と皮
膚付着シート4を、計量分薬剤5を有する担体箔
1と閉鎖ステーシヨンの堆積マガジンから取り出
したカバーシート片3′とに結合する前に分離し
て、中間層シート2に計量分薬剤5と同じ大きさ
の穴をあけ、穴のあいた中間層シート2と計量
分薬剤5を収容してある担体箔1とを一緒に案内
して計量分薬剤の周囲で相互に接合し、その上に
皮膚付着シート4の付着側を載置する、薬剤を間
隔をおいて計量分づつ外皮である帯状の担体箔の
一部分に継続して収容してできた硬膏包装体を打
ち抜くことを特徴とする方法。 2 計量分薬剤の収容前に担体箔1に偏平に深絞
りした小深皿部5′を備える、特許請求の範囲1
に記載の方法。 3 皮膚に貼り付ける部分と、剥がして捨てる部
分とから成り、皮膚に貼り付ける部分は、薬剤と
この薬剤を被うカバーシート片と更にその上の薄
く、弾力性がある発泡ゴム状の皮膚付着シートと
から成り、剥がして捨てる部分は薬剤を収容する
単体箔と、この担体箔と前記皮膚付着シートとの
接着を防止するためのリング状の中間層シートか
ら成る硬膏包装体を連続的に製造する方法におい
て、計量分薬剤と同じ大きさの穴をあけてある中
間層シート2を担体箔1と一緒に案内して前記
穴の周囲で相互に接合し、次に計量分薬剤5を穴
あき中間層シート2によつて被われていない担
体箔1の領域に収容して計量分薬剤を予め打抜か
れたカバーシート片3′で被い、カバーシート片
3′を計量分薬剤の周囲で担体箱1に封着した後、
保護シート2″を剥がしてある皮膚付着シート4
を被着する、薬剤を計量分づつ外皮である帯状の
担体箔の一部分に間隔をおいて継続して載置して
できた硬膏包装体を打ち抜くことを特徴とする方
法。 4 計量分薬剤の収容前に担体箔1に偏平に深絞
りした小深皿部5′を備える、特許請求の範囲3
に記載の方法。 5 中間層シート2として皮膚付着シート4から
引き離された保護シート2を使用する、特許請
求の範囲3に記載の方法。 6 皮膚に貼り付ける部分と、剥がして捨てる部
分とから成り、皮膚に貼り付ける部分は、薬剤と
この薬剤を被うカバーシート片と更にその上の薄
く、弾力性がある発泡ゴム状の皮膚付着シートと
から成り、剥がして捨てる部分は薬剤を収容した
担体箔と、この担体箔と前記皮膚付着シートとの
接着を防止するためのリング状の中間層シートか
ら成る硬膏包装体を連続的に製造する方法におい
て、担体箔1に計量分薬剤5を収容し、この計量
分薬剤5をカバーシート片3′で被つて計量分薬
剤5の周囲で担体箔1に封着し、次に皮膚付着シ
ートから分離して計量分薬剤と同じ大きさの穴を
あけてある中間層シート2を給送して担体箔1
に計量分薬剤5の周囲で封着し、次いでカバーシ
ート片3′と中間層シート2の上から、保護シ
ート2″を分離してある皮膚付着シート4の付着
側を載せる、薬剤を計量分づつ外皮である帯状の
担体箔の一部分に間隔をおいて継続して収容して
できた硬膏包装体を打ち抜くことを特徴とする方
法。 7 計量分薬剤の収容前に担体箔1に偏平に深絞
りした小深皿部5′を備える、特許請求の範囲6
に記載の方法。 8 中間層シート2として皮膚付着シート4から
引き離された保護シート2を使用する、特許請
求の範囲6に記載の方法。 9 皮膚に貼り付ける部分と、剥がして捨てる部
分とから成り、皮膚に貼り付ける部分は、薬剤と
この薬剤を被うカバーシート片と更にその上の薄
く、弾力性がある発泡ゴム状の皮膚付着シートと
から成り、剥がして捨てる部分は担体箔と、この
担体箔と前記皮膚付着シートとの接着を防止する
ための中間層シートから成る硬膏包装体を連続的
に製造する方法において、担体箔1を積層した中
間層シート2の上に計量分薬剤を収容し、この計
量分薬剤をカバーシート片3′で被い、計量分薬
剤5の周囲で担体箔1と中間層シート2とカバー
シート片3′を封着し、次に皮膚付着シート4の
付着側をカバーシート片3′の上に載せる、薬剤
を間隔をおいて計量分づつ中間層シートの一部に
継続して収容してできた硬膏包装体を打ち抜くこ
とを特徴とする方法。[Scope of Claims] 1. Consists of a part that is attached to the skin and a part that is peeled off and discarded.The part that is attached to the skin includes a drug, a cover sheet piece that covers the drug, and a thin, elastic sheet above the drug. The plaster packaging consists of a foamed rubber-like skin adhesive sheet, and the part that is peeled off and thrown away is a carrier foil that contains the drug, and a ring-shaped intermediate layer sheet that prevents adhesion between the carrier foil and the skin adhesive sheet. In a method for continuously manufacturing a body, a strip-shaped interlayer sheet 2 and a skin-adhesive sheet 4, which are fed together, a carrier foil 1 with a dose of drug 5 and a cover sheet piece removed from a depositing magazine of a closed station. 3', the intermediate layer sheet 2 is separated and a hole of the same size as the measured amount of drug 5 is made, and the carrier foil 1 containing the perforated intermediate layer sheet 2 and the measured amount of drug 5 is separated. are guided together and joined to each other around the measured amount of drug, and the adhesion side of the skin adhesion sheet 4 is placed on top of it. A method characterized by punching out a plaster package formed by continuous filling in one part. 2. Claim 1, comprising a small deep dish portion 5' that is deep-drawn into a flat shape on the carrier foil 1 before storing the measured amount of medicine.
The method described in. 3. It consists of a part that is attached to the skin and a part that is peeled off and thrown away.The part that is attached to the skin consists of the drug, a piece of cover sheet that covers the drug, and a thin, elastic foam rubber-like skin adhesive on top of the drug. Continuously manufactures a plaster package consisting of a sheet, the part of which is peeled off and disposed of is a single foil containing the drug, and a ring-shaped intermediate layer sheet to prevent adhesion between this carrier foil and the skin adhesion sheet. In the method of A dose of drug contained in the area of the carrier foil 1 that is not covered by the intermediate layer sheet 2 is covered with a pre-stamped cover sheet piece 3', and the cover sheet piece 3' is placed around the metered dose of drug to cover the carrier foil. After sealing in box 1,
Skin adhesion sheet 4 with protective sheet 2'' removed
A method characterized by punching out a plaster package made by continuously placing measured amounts of the drug at intervals on a portion of a band-shaped carrier foil that is the outer skin. 4. Claim 3, wherein the carrier foil 1 is provided with a small deep-dish portion 5' that is deep-drawn into a flat shape before storing the measured amount of medicine.
The method described in. 5. The method according to claim 3, wherein the protective sheet 2 separated from the skin adhesive sheet 4 is used as the intermediate layer sheet 2. 6. It consists of a part that is attached to the skin and a part that is peeled off and discarded.The part that is attached to the skin consists of the drug, a piece of cover sheet that covers the drug, and a thin, elastic foam rubber-like skin adhesive on top of the drug. Continuously manufacture plaster packages consisting of a carrier foil containing a drug and a ring-shaped intermediate layer sheet to prevent adhesion between the carrier foil and the skin adhesion sheet, the part of which is peeled off and thrown away. In this method, a measured amount of drug 5 is stored in a carrier foil 1, this measured amount of drug 5 is covered with a cover sheet piece 3' and sealed around the measured amount of drug 5 to the carrier foil 1, and then a skin adhesion sheet is placed. The intermediate layer sheet 2, which has holes of the same size as the measurable drug, is separated from the carrier foil 1 and fed.
A measured amount of the drug is sealed around the drug 5, and then the adhering side of the skin adhesion sheet 4 from which the protective sheet 2'' has been separated is placed on the cover sheet piece 3' and the intermediate layer sheet 2. A method characterized by punching out a plaster package formed by continuously accommodating a portion of a band-shaped carrier foil, which is an outer shell, at intervals. Claim 6, comprising a narrowed small deep dish portion 5'.
The method described in. 8. The method according to claim 6, wherein the protective sheet 2 separated from the skin adhesive sheet 4 is used as the intermediate layer sheet 2. 9 Consists of a part that is attached to the skin and a part that is peeled off and thrown away.The part that is attached to the skin consists of the drug, a cover sheet piece that covers the drug, and a thin, elastic foam rubber-like skin adhesive on top of the drug. In a method for continuously manufacturing a plaster package, the part of which is peeled off and discarded is a carrier foil, and an intermediate layer sheet for preventing adhesion between the carrier foil and the skin adhesive sheet. A measured amount of drug is stored on the intermediate layer sheet 2 laminated with the above, and this measured amount of drug is covered with a cover sheet piece 3'. 3' is sealed, and then the adhesive side of the skin adhesive sheet 4 is placed on the cover sheet piece 3'. A method characterized by punching out a plaster package.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14261983A JPS6040054A (en) | 1983-08-05 | 1983-08-05 | Continuous production of hard bandage pack for skin perviousadministration of drug |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14261983A JPS6040054A (en) | 1983-08-05 | 1983-08-05 | Continuous production of hard bandage pack for skin perviousadministration of drug |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6040054A JPS6040054A (en) | 1985-03-02 |
JPH0370498B2 true JPH0370498B2 (en) | 1991-11-07 |
Family
ID=15319542
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP14261983A Granted JPS6040054A (en) | 1983-08-05 | 1983-08-05 | Continuous production of hard bandage pack for skin perviousadministration of drug |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6040054A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6063344U (en) * | 1983-10-06 | 1985-05-04 | 丸正金属箔工業株式会社 | Container for poultice |
-
1983
- 1983-08-05 JP JP14261983A patent/JPS6040054A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS6040054A (en) | 1985-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0755284B1 (en) | A topical dressing, method of manufacturing a topical dressing and use of a topical dressing | |
US4158411A (en) | Dispensing package | |
US3069273A (en) | Method of packaging | |
CN100515881C (en) | Dispensing container and dispensing container covering film | |
US8740003B2 (en) | Dispensing containers | |
US3912081A (en) | Child resistant package | |
US6571983B1 (en) | Method and device for dispensing flat forms | |
US3070225A (en) | Package and method of making same | |
JP4541551B2 (en) | Method for producing an adhesive punched product from an endless band, and a punched product produced by this method | |
JP5903437B2 (en) | seal | |
GB2069970A (en) | Method of producing force-through packages provided with adhesive labels | |
JPH0858840A (en) | Blister pack | |
IL124618A (en) | Process for the production of transdermal therapeutic patches | |
JPS5841051A (en) | Small bag and its manufacture | |
DE3204582C2 (en) | ||
US3234705A (en) | Method of making a package | |
JP3504249B2 (en) | Multiple container | |
JPS5934585B2 (en) | Overpressure valve for packaging containers | |
EP0919211A2 (en) | Wound dressing | |
JPH0370498B2 (en) | ||
US8104986B2 (en) | Liquid applicator | |
DE19830898A1 (en) | Device for improving the removal ability of flat, substrate-packed sections packed in pouches with a pressure-sensitive adhesive | |
JPH09501909A (en) | Transdermal delivery system package | |
JP2003170960A (en) | Belt shaped body for supplying packaged body attached sheet and its production method | |
JPH018534Y2 (en) |